Literature DB >> 18806917

Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.

Jacqueline Hoeppner1, Lara Prudente-Morrissey, Sabine Christiane Herpertz, Reiner Benecke, Uwe Walter.   

Abstract

BACKGROUND: Substantia nigra hyperechogenicity (SNH) is a characteristic transcranial sonography (TCS) finding in Parkinson's disease (PD). SNH, found also in about 10% of healthy adults, was related to a subclinical malfunction of the nigrostriatal dopaminergic system on positron emission tomography studies. Both, liability for developing PD and frequency of SNH were found to be increased in depressed subjects. Here, we investigated whether SNH in depression is related to motor or cognitive abnormalities resembling early PD.
METHODS: Fourty-one patients with major depressive disorder and 15 with adjustment disorder with depressed mood were studied clinically and with TCS.
RESULTS: Frequency of SNH was similar in both groups (39, 33%; Chi-square test, P = 0.70). Larger SN echogenic size correlated with larger right-to-left asymmetry of finger tapping (Spearman test, r = 0.37, P = 0.009) and lower verbal fluency (r = -0.35, P = 0.038). These correlations were stronger in patients at ages >/= 50 years (r = 0.52, P = 0.007; r = -0.50, P = 0.020), and, independently from age, in patients with reduced echogenicity of brainstem raphe suggested to reflect alteration of the serotonergic system (r = 0.40, P = 0.045; r = -0.51, P = 0.044). Whereas bilateral sum score of finger tapping was negatively correlated with severity of depression on the beck depression inventory (r = -0.50, P = 0.001) and the Hamilton depression rating scale (r = -0.34, P = 0.019), no correlation was found between depression severity and tapping asymmetry, or between depression severity and verbal fluency.
CONCLUSION: Data suggest that TCS detects a subgroup of patients with depression characterized by symptoms of early parkinsonism who are possibly at an elevated risk of later developing definite PD.

Entities:  

Mesh:

Year:  2008        PMID: 18806917     DOI: 10.1007/s00406-008-0840-9

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  35 in total

1.  Brain parenchyma sonography detects preclinical parkinsonism.

Authors:  Uwe Walter; Christine Klein; Ruediger Hilker; Reiner Benecke; Peter P Pramstaller; Dirk Dressler
Journal:  Mov Disord       Date:  2004-12       Impact factor: 10.338

2.  The impact of deep brain stimulation on executive function in Parkinson's disease.

Authors:  M Jahanshahi; C M Ardouin; R G Brown; J C Rothwell; J Obeso; A Albanese; M C Rodriguez-Oroz; E Moro; A L Benabid; P Pollak; P Limousin-Dowsey
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

3.  The motor agitation and retardation scale: a scale for the assessment of motor abnormalities in depressed patients.

Authors:  C Sobin; L Mayer; J Endicott
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1998       Impact factor: 2.198

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  Increased risk of Parkinson's disease after depression: a retrospective cohort study.

Authors:  A G Schuurman; M van den Akker; K T J L Ensinck; J F M Metsemakers; J A Knottnerus; A F G Leentjens; F Buntinx
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

6.  Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers.

Authors:  Petra Ruprecht-Dörfler; Patricia Klotz; Georg Becker; Daniela Berg
Journal:  Parkinsonism Relat Disord       Date:  2006-10-18       Impact factor: 4.891

7.  Relationship of substantia nigra echogenicity and motor function in elderly subjects.

Authors:  D Berg; C Siefker; P Ruprecht-Dörfler; G Becker
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

8.  Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study.

Authors:  M Brandt-Christensen; K Kvist; F M Nilsson; P K Andersen; L V Kessing
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

9.  Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.

Authors:  Uwe Walter; Jacqueline Hoeppner; Lara Prudente-Morrissey; Sebastian Horowski; Sabine C Herpertz; Reiner Benecke
Journal:  Brain       Date:  2007-02-28       Impact factor: 13.501

10.  Drug-induced parkinsonism.

Authors:  J A Van Gerpen
Journal:  Neurologist       Date:  2002-11       Impact factor: 1.398

View more
  12 in total

Review 1.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

Review 2.  [Early recognition of Parkinson's disease. Objectifiable non-motor symptoms and biomarkers].

Authors:  B Mollenhauer; F Sixel-Döring; A Storch; C Schneider; R Hilker; E Kalbe
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

3.  Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders.

Authors:  Victor Peralta; Virginia Basterra; Maria S Campos; Elena García de Jalón; Lucía Moreno-Izco; Manuel J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-05-28       Impact factor: 5.270

4.  Brainstem raphe lesion in patients with major depressive disorder and in patients with suicidal ideation recorded on transcranial sonography.

Authors:  Mislav Budisic; Budisic Mislav; Dalibor Karlovic; Karlovic Dalibor; Zlatko Trkanjec; Trkanjec Zlatko; Arijana Lovrencic-Huzjan; Lovrencic-Huzjan Arijana; Vlasta Vukovic; Vukovic Vlasta; Jelena Bosnjak; Bosnjak Jelena; Vida Demarin; Demarin Vida
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-09-15       Impact factor: 5.270

5.  Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study.

Authors:  Uwe Walter; Robert Heilmann; Lara Kaulitz; Tino Just; Bernd Joachim Krause; Reiner Benecke; Jacqueline Höppner
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

6.  Influence of repetitive transcranial magnetic stimulation on psychomotor symptoms in major depression.

Authors:  Jacqueline Hoeppner; Frank Padberg; Gregor Domes; Antonia Zinke; Sabine C Herpertz; Nicola Grossheinrich; Uwe Herwig
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-08-13       Impact factor: 5.270

7.  Achievement and maintenance of the new impact factor 2010.

Authors:  P Falkai; H-J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09       Impact factor: 5.270

8.  Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.

Authors:  Kristina Laučkaitė; Daiva Rastenytė; Danguolė Šurkienė; Antanas Vaitkus; Andrius Sakalauskas; Arūnas Lukoševičius; Rymantė Gleiznienė
Journal:  BMC Neurol       Date:  2012-03-08       Impact factor: 2.474

Review 9.  The functional anatomy of psychomotor disturbances in major depressive disorder.

Authors:  Benny Liberg; Christoffer Rahm
Journal:  Front Psychiatry       Date:  2015-03-10       Impact factor: 4.157

Review 10.  Neural and behavioral substrates of subtypes of Parkinson's disease.

Authors:  Ahmed A Moustafa; Michele Poletti
Journal:  Front Syst Neurosci       Date:  2013-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.